Release Date: 02/02/15 09:19 Summary: Second Quarter Activities Report Price Sensitive: No Download Document 79.44KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%